Sepio Capital’s Elevance Health ELV Stock Holding History

Sepio Capital’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-610	Closed	-$236K	–	321
2026 Q2	$236K	Buy	+610	New	+$226K	0.01%	317
2026 Q1	–	Sell	-573	Closed	-$201K	–	384
2025 Q4	$201K	Buy	+573	New	+$194K	0.01%	352
2023 Q2	–	Sell	-5,219	Closed	-$2.4M	–	344
2023 Q1	$2.4M	Buy	5,219 +176	+3%	+$83.8K	0.22%	131
2022 Q4	$2.59M	Buy	+5,043	New	+$2.56M	0.22%	115
2022 Q1	–	Sell	-9,429	Closed	-$4.37M	–	358
2021 Q4	$4.37M	Sell	9,429 -3,294	-26%	-$1.39M	0.32%	92
2021 Q3	$4.74M	Buy	12,723 +1,818	+17%	+$691K	0.39%	70
2021 Q2	$4.16M	Buy	+10,905	New	+$4.17M	0.34%	83

Other funds holding ELV

Sanders Capital West Palm Beach, Florida $103B AUM 36.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

ACR Alpine Capital Research St. Louis, Missouri $7.35B AUM 21.37% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

High Ground Investment Management London, United Kingdom $1.3B AUM 17.7% 1-Year Est. Return

Sepio Capital's ELV Position: Q3 2026 in Review

Sepio Capital sold out of Elevance Health (ELV) in Q3 2026, closing a stake of 610 shares — an estimated $236K sold.

Sepio Capital first reported a position in ELV in Q2 2021 and held it in 7 quarters. The position peaked at $4.74M in Q3 2021. 866 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

Sepio Capital reported no remaining Elevance Health position as of Q3 2026 after selling out during the quarter.
Sepio Capital sold 610 Elevance Health shares in Q3 2026, an estimated $236K.
Sepio Capital first reported a position in Elevance Health in Q2 2021 and held it in 7 quarters.
Sepio Capital's Elevance Health position peaked at $4.74M in Q3 2021.
866 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Sepio Capital's 13F filing for Q3 2026, filed 22 Oct 2026.